Serum Concentration of Procollagen Type III Amino-Terminal Peptide is Increased in Patients with Successfully Repaired Coarctation of the Aorta with Left Ventricular Hypertrophy

详细信息    查看全文

• 作者：Hirokuni Yamazawa ; Tomoaki Murakami ; Atsuhito Takeda ; Kouta Takei…
• 关键词：Procollagen type III amino ; terminal peptide ; Coarctation of the aorta ; Left ventricular hypertrophy ; Myocardial fibrosis ; Renin ; angiotensin ; aldosterone system
• 刊名：Pediatric Cardiology
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：36
• 期：3
• 页码：555-560
• 全文大小：194 KB
• 参考文献：1. Brili S, Dernellis J, Aggeli C, Pitsavos C, Hatzos C, Stefanadis C et al (1998) Aortic elastic properties in patients with repaired coarctation of aorta. Am J Cardiol 82(1140-):A10
  2. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O et al (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251-260 CrossRef
  3. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25:1056-062 CrossRef
  4. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450-58 CrossRef
  5. Diez J (2007) Mechanisms of cardiac fibrosis in hypertension. J Clin Hypertens (Greenwich) 9:546-50 CrossRef
  6. Diez J, Lopez B, Gonzalez A, Querejeta R (2001) Clinical aspects of hypertensive myocardial fibrosis. Curr Opin Cardiol 16:328-35 CrossRef
  7. Eerola A, Jokinen E, Boldt T, Mattila IP, Pihkala JI (2007) Left ventricular hypertrophy persists after successful treatment for coarctation of the aorta. Scand Cardiovasc J 41:370-77 CrossRef
  8. Foster BJ, Mackie AS, Mitsnefes M, Ali H, Mamber S, Colan SD (2008) A novel method of expressing left ventricular mass relative to body size in children. Circulation 117:2769-775 CrossRef
  9. Lammi L, Ryhanen L, Lakari E, Risteli J, Paakko P, Kahlos K et al (1999) Type III and type I procollagen markers in fibrosing alveolitis. Am J Respir Crit Care Med 159:818-23 CrossRef
  10. Lawrie GM, DeBakey ME, Morris GC Jr, Crawford ES, Wagner WF, Glaeser DH (1981) Late repair of coarctation of the descending thoracic aorta in 190 patients. Results up to 30?years after operation. Arch Surg 116:1557-560 CrossRef
  11. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1989) Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med 110:101-07 CrossRef
  12. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561-566 CrossRef
  13. Maron BJ, Humphries JO, Rowe RD, Mellits ED (1973) Prognosis of surgically corrected coarctation of the aorta. A 20-year postoperative appraisal. Circulation 47:119-26 CrossRef
  14. Murakami T, Takeda A (2005) Enhanced aortic pressure wave reflection in patients after repair of aortic coarctation. Ann Thorac Surg 80:995-99 CrossRef
  15. Nakahara T, Takata Y, Hirayama Y, Asano K, Adachi H, Shiokawa G et al (2007) Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide. Circ J 71:716-21 CrossRef
  16. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M et al (2009) The Japanese Society of Hyperten
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Cardiology
  Cardiac Surgery
  Vascular Surgery
  
• 出版者：Springer New York
• ISSN：1432-1971

文摘

Pathological left ventricular hypertrophy (LVH) with myocardial fibrosis is an independent risk factor for cardiovascular mortality. Previous studies indicated that patients with coarctation of the aorta (CoA) have increased left ventricular mass (LVM) including LVH, even after successful CoA repair. It is unclear whether the increased LVM is pathological one with cardiac fibrosis. Group A consisted of 17 patients with successfully repaired CoA. Group B consisted of 17 postoperative subjects who matched the age and postoperative periods of group A. Group C comprised 28 subjects for the geometric standard of the left ventricle. The LVM index (LVMI) and the relative wall thickness (RWT) of group A and B were compared with the values of 17 age-matched subjects from group C. The serum concentration of procollagen type III amino-terminal peptide (P-III-P), a biomarker for myocardial fibrosis, in group A was compared with the concentration in group B. The correlations between the serum P-III-P concentration and LVMI and RWT were studied in group A and non-A group. In group A, RWT and LVMI were significantly higher than those in group C (0.37?±?0.05 vs. 0.31?±?0.02, p?p?=?0.04, respectively), and the serum P-III-P concentration was significantly higher than that in group B (1.59?±?0.74 vs. 1.07?±?0.33, p?=?0.04). Serum P-III-P concentrations were well correlated with RWT and LVMI (r?=?0.89, p?r?=?0.63, p?CoA may have an abnormal pathogenesis associated with myocardial fibrosis.